Becton, Dickinson and Company (BDX)
Automate Your Wheel Strategy on BDX
With Tiblio's Option Bot, you can configure your own wheel strategy including BDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BDX
- Rev/Share 76.1971
- Book/Share 88.5832
- PB 2.3311
- Debt/Equity 0.7555
- CurrentRatio 1.1133
- ROIC 0.0473
- MktCap 58938935738.0
- FreeCF/Share 9.3157
- PFCF 22.0745
- PE 35.2714
- Debt/Assets 0.3467
- DivYield 0.0202
- ROE 0.0663
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | BDX | Citigroup | -- | Buy | -- | $233 | Feb. 3, 2026 |
| Initiation | BDX | RBC Capital Mkts | -- | Sector Perform | -- | $211 | Sept. 25, 2025 |
| Downgrade | BDX | Citigroup | Buy | Neutral | -- | $185 | May 22, 2025 |
| Downgrade | BDX | Raymond James | Outperform | Market Perform | -- | -- | May 2, 2025 |
| Downgrade | BDX | Goldman | Buy | Neutral | -- | $192 | May 2, 2025 |
| Downgrade | BDX | Piper Sandler | Overweight | Neutral | -- | $185 | May 2, 2025 |
| Downgrade | BDX | William Blair | Outperform | Market Perform | -- | -- | May 1, 2025 |
| Downgrade | BDX | BofA Securities | Buy | Neutral | -- | $190 | May 1, 2025 |
| Downgrade | BDX | Wells Fargo | Overweight | Equal Weight | -- | -- | May 1, 2025 |
| Upgrade | BDX | Citigroup | Neutral | Buy | $255 | $275 | Oct. 1, 2024 |
News
Becton, Dickinson and Company (BDX) Citi's 2025 Unplugged Medtech and Life Sciences Access Day Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Becton, Dickinson and Company (NYSE:BDX ) Citi's 2025 Unplugged Medtech and Life Sciences Access Day November 27, 2025 8:45 AM ET Company Participants Tom Polen – Chairman, Chief Executive Officer and President Chris DelOrefice – Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch – Citi Joanne Wuensch We're live? Excellent.
Read More
My Best Dividend Aristocrats For March 2025
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF kicks off 2025 on a bright note with a gain of 2.81% in January. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 43 months of tracking these strategies, one strategy is generating a CAGR superior to NOBL.
Read More
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
About Becton, Dickinson and Company (BDX)
- IPO Date 1973-02-21
- Website https://www.bd.com
- Industry Medical - Instruments & Supplies
- CEO Thomas E. Polen Jr.
- Employees 70000